Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Preclinical studies indicate potential of TAK-147 for AD

April 14, 1997

Novel heterocyclic 5-HT1B receptor antagonists disclosed by SKB

April 14, 1997

Antioxidants/sodium channel blockers from Takeda

April 14, 1997

Fournier discloses bradykinin antagonists

April 14, 1997

Astra reveals novel opioid peptides

April 14, 1997

PEP inhibitors from Chinoin

April 14, 1997

Pfizer reports new salt of known NMDA antagonist

April 14, 1997

First launch for new indication of cabergoline

April 11, 1997

Synthelabo prepares serotonergic agents

April 11, 1997

Arzneimittelwerk describes novel antiepileptic agents

April 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.